The National Multiple Sclerosis (MS) Society has developed recommendations for the identification and management of...
BERLIN – Risk factors for higher disease activity include younger age at diagnosis, shorter disease duration, and stopping more than 2 months...
BERLIN – Age and anti-MOG antibody status may help to predict a non-MS diagnosis.
BERLIN—Higher vitamin D levels at multiple sclerosis (MS) onset predict higher cognitive function 11 years later,...
BERLIN—Relapse-induced escalation to a highly effective disease-modifying therapy (DMT) is associated...
BERLIN—Spinal cord volume deficits in patients with multiple sclerosis (MS) may explain clinical disability that appears...
BERLIN—Smoking and low vitamin D levels are key modifiable prognostic factors that show a significant interaction with...
BERLIN—Switching from interferon beta-1a to ocrelizumab after two years at the start of the OPERA I and OPERA II open-...
BERLIN—Levels of neurofilament light chain (NfL) indicate that patients with secondary progressive...
BERLIN—Vitamin D increases the therapeutic effects of glucocorticoids via an mTORc1–dependent upregulation of the...
BERLIN—The risk of cancer, and breast cancer in particular, was not elevated above background levels in...
BERLIN—Depression and bipolar disorder are major risk factors for worsening disability in people with multiple sclerosis...
BERLIN—Gray matter–white matter (GM/WM) contrast ratio on T1 magnetization prepared rapid gradient echo (MPRAGE) is...
BERLIN—Research supports the previously observed association of periventricular lesions with cortical thinning in...
BERLIN—Applying the 2017 McDonald criteria to children is feasible and allows an earlier diagnosis of multiple sclerosis...
